ES411602A2 - Purification of glycoproteins - Google Patents

Purification of glycoproteins

Info

Publication number
ES411602A2
ES411602A2 ES411602A ES411602A ES411602A2 ES 411602 A2 ES411602 A2 ES 411602A2 ES 411602 A ES411602 A ES 411602A ES 411602 A ES411602 A ES 411602A ES 411602 A2 ES411602 A2 ES 411602A2
Authority
ES
Spain
Prior art keywords
glycoproteins
beta
inactive
membranes
diafiltration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES411602A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES411602A2 publication Critical patent/ES411602A2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Improvements introduced in the object of the main patent No. 379,815, granted on June 20, 1972 for: "A procedure for the preparation of slow alpha and beta-glycoproteins", extracted from cultures of microbial strains chosen from the group chosen by Pneumococci, Streptococci, Neisseria, Micrococci, Staphylococci, Klebsiella Pneumoníae and Hemophilus Influenzae or from a mixture of these germs or from an association of different types of one of these microbial species, characterized by the fact that it undergoes slow alpha and beta-glycoproteins to a diafiltration in aqueous solution on one or more calibrated membranes that play the role of molecular sieves, by using one or more types of membranes, the inactive or inactive fractions are separated, the very pure fractions retained by the membrane are collected in the diafiltration cell, undergo chromatography on hydrophilic polymerized gel and collect the fraction not fixed. (Machine-translation by Google Translate, not legally binding)
ES411602A 1972-02-15 1973-02-14 Purification of glycoproteins Expired ES411602A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7205016A FR2171907B2 (en) 1972-02-15 1972-02-15

Publications (1)

Publication Number Publication Date
ES411602A2 true ES411602A2 (en) 1976-03-01

Family

ID=9093508

Family Applications (1)

Application Number Title Priority Date Filing Date
ES411602A Expired ES411602A2 (en) 1972-02-15 1973-02-14 Purification of glycoproteins

Country Status (12)

Country Link
JP (2) JPS4896792A (en)
BE (1) BE795417A (en)
CA (1) CA993389A (en)
CH (1) CH564084A5 (en)
DE (1) DE2307051C3 (en)
DK (1) DK146724C (en)
ES (1) ES411602A2 (en)
FR (1) FR2171907B2 (en)
GB (1) GB1412202A (en)
HU (1) HU168849B (en)
NL (1) NL174267C (en)
SE (1) SE425833B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (en) * 1978-05-26 1982-11-30 Om Laboratoires Sa MEDICINE FOR INFECTIOUS DISEASES OF THE RESPIRATORY TRACT.
FR2462477A1 (en) * 1979-07-31 1981-02-13 Cassenne Lab Sa NOVEL KLEBSIELLA PNEUMONIAE GLYCOPROTEINS, PROCESS FOR OBTAINING THEM, APPLICATION AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM
FR2490496A1 (en) * 1980-09-19 1982-03-26 Roussel Uclaf NEW IMMUNOSTIMULANT GLYCOPROTEINS EXTRACTED FROM KLEBSIELLA PNEUMONIAE, PROCESS FOR OBTAINING THEM, THEIR APPLICATION AS MEDICAMENTS AND COMPOSITIONS COMPRISING THE SAME
FR2490495A1 (en) * 1980-09-19 1982-03-26 Roussel Uclaf NOVEL HYDROSOLUBLE IMMUNOSTIMULANT GLYCOPROTEINS EXTRACTED FROM KLEBSIELLA PNEUMONIAE, PROCESS FOR OBTAINING THEM, USE THEREOF AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM
FR2523154A1 (en) * 1982-03-09 1983-09-16 Fabre Sa Pierre PROCESS FOR THE PREPARATION OF INTERFERON-INDUCING IMMUNOSTIMULATING PROTEOGLYCANS, PROTEOGLYCANS OBTAINED AND MEDICAMENTS CONTAINING THEM
FR2574429B1 (en) * 1984-12-06 1987-12-11 Roussel Uclaf ACYLGLYCANNES EXTRACTED FROM KLEBSIELLA, PROCESS FOR OBTAINING THEM, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
IT1199301B (en) * 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan BACTERIAL ANTIGENIC LYSATE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
FR2653014B1 (en) * 1989-10-17 1994-09-16 Roussel Uclaf USE OF GLYCOPROTEINS EXTRACTED FROM GRAM (-) BACTERIA FOR THE MANUFACTURE OF COSMETIC OR DERMATOLOGICAL COMPOSITIONS AND COMPOSITIONS CONTAINING THEM.
CH699786A2 (en) * 2008-10-31 2010-05-14 Marie-Christine Dr Etienne Medicament TREATING INFECTIONS.

Also Published As

Publication number Publication date
FR2171907A2 (en) 1973-09-28
BE795417A (en) 1973-08-14
GB1412202A (en) 1975-10-29
DE2307051C3 (en) 1980-06-19
NL174267C (en) 1984-05-16
DK146724C (en) 1984-05-28
FR2171907B2 (en) 1975-04-25
JPS4896792A (en) 1973-12-10
CH564084A5 (en) 1975-07-15
JPS6028813B2 (en) 1985-07-06
HU168849B (en) 1976-07-28
DE2307051B2 (en) 1979-10-04
DK146724B (en) 1983-12-12
CA993389A (en) 1976-07-20
JPS59219236A (en) 1984-12-10
SE425833B (en) 1982-11-15
NL7302132A (en) 1973-08-17
DE2307051A1 (en) 1973-08-23

Similar Documents

Publication Publication Date Title
Melish et al. The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin
GB2217717B (en) Process for the production of porous membranes,the membranes produced thereby and their use as supporting matrices in test strips
IT987281B (en) APPARATUS FOR CEL LULE CULTURE ON SEMIPERMEABLE TUBULAR MEMBRANES
IT1019215B (en) SEMIPERMEABLE MEMBRANE USEFUL IN PARTICULAR FOR THE SEPARATION OF SUBSTANCES AND PROCEDURE FOR ITS PRODUCTION
DE3070021D1 (en) Porous semipermeable membrane based on polyacrylonitrile modified by amidoxime groups, process for its preparation and their use
Masson et al. Appearance of cytolytic granules upon induction of cytolytic activity in CTL‐hybrids.
AR228060A1 (en) PREPARATION PROCESS FOR POROUS FIBER HEME MEMBRANE FOR PLASMA SEPARATION
BE783835A (en) PROCESS FOR PREPARING SEMI-PERMEABLE ANISOTROPIC MEMBRANES IN POLYARYLETHER / SULPHONES
Muramatsu et al. Carbohydrate portion of membrane-located mouse H-2 alloantigens
DK517485D0 (en) MEMBRANE STRUCTURE WITH CONTINUOUS PORTS
BE752884A (en) PROCESS FOR PREPARING THE ALLYL ALCOHOL
CH551151A (en) PROCESS FOR PREPARING A FRACTION OF SOY PROTEINS.
AU469067B2 (en) Apparatus for separating fluids into two fractions by means of semipermeable membranes
Madoff et al. Purification of staphylococcal alpha-hemolysin
ES379815A1 (en) Proteins
ES437046A2 (en) Manufacture of novel amino acid derivative
ES418397A1 (en) Milk products
Parmely et al. Effect of α-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response
ES449093A1 (en) 1,2,2,2-Tetrafluoroethyl ethers and process for preparing them
GB1412202A (en) Purification of glycoproteins
Hardwicke et al. Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods
ES391350A2 (en) A procedure for the preparation of alpha- and beta-glicoproteinas slows. (Machine-translation by Google Translate, not legally binding)
ES322427A1 (en) Procedure for the obtaining of a composition used as excipient in pharmaceutical preparations. (Machine-translation by Google Translate, not legally binding)
Affronti et al. Some early investigations of Mycobacterium tuberculosis
US3949069A (en) Nitrogen-containing carbohydrate

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170704